The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Lipid based nanocarriers: a translational perspective
Abstract
Over the recent couple of decades, pharmaceutical field has embarked most phenomenal noteworthy achievements in the field of medications as well as drug delivery. The rise of Nanotechnology in this field has reformed the existing drug delivery for targeting, diagnostic, remedial applications and patient monitoring. The convincing usage of nanotechnology in the conveyance of medications that prompts an extension of novel lipid-based nanocarriers and non-liposomal systems has been discussed. Present review deals with the late advances and updates in lipidic nanocarriers, their formulation strategies, challenging aspects, stability profile, clinical applications alongside commercially available products and products under clinical trials. This exploration may give a complete idea viewing the lipid based nanocarriers as a promising choice for the formulation of pharmaceutical products, the challenges looked by the translational process of lipid-based nanocarriers and the combating methodologies to guarantee the headway of these nanocarriers from bench to bedside.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Kamaly, N., Xiao, Z., Valencia, P. M., Radovic-Moreno, A. F., & Farokhzad, O. C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15344k · Cited by 1,730
Carbon nanotubes in biology and medicine: In vitro and in vivo detection, imaging and drug delivery
Liu, Z., Tabakman, S., Welsher, K., & Dai, H. (2009) · Nano Research · doi:10.1007/s12274-009-9009-8 · Cited by 1,716
Drug Delivery with Carbon Nanotubes for In vivo Cancer Treatment
Liu, Z., Chen, K., Davis, C., Sherlock, S., Cao, Q., Chen, X., & Dai, H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1468 · Cited by 1,348
Low, P. S., Henne, W. A., & Doorneweerd, D. D. (2008) · Accounts of Chemical Research · doi:10.1021/ar7000815 · Cited by 1,173
Pan, L., He, Q., Liu, J., Chen, Y., Ma, M., Zhang, L., & Shi, J. (2012) · Journal of the American Chemical Society · doi:10.1021/ja211035w · Cited by 984
Biological properties of “naked” metal nanoparticles☆
BHATTACHARYA, R., & MUKHERJEE, P. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.013 · Cited by 917
Meng, H., Liong, M., Xia, T., Li, Z., Ji, Z., Zink, J. I., & Nel, A. E. (2010) · ACS Nano · doi:10.1021/nn100690m · Cited by 902
Pouton, C. W., & Porter, C. J. H. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.010 · Cited by 885
Xie, J., Xu, C., Kohler, N., Hou, Y., & Sun, S. (2007) · Advanced Materials · doi:10.1002/adma.200701975 · Cited by 686
Feng, T., Ai, X., An, G., Yang, P., & Zhao, Y. (2016) · ACS Nano · doi:10.1021/acsnano.6b00043 · Cited by 650
Meng, H., Mai, W. X., Zhang, H., Xue, M., Xia, T., Lin, S., Wang, X., Zhao, Y., Ji, Z., Zink, J. I., et al. (2013) · ACS Nano · doi:10.1021/nn3044066 · Cited by 575
Phytosomal curcumin: A review of pharmacokinetic, experimental and clinical studies
Mirzaei, H., Shakeri, A., Rashidi, B., Jalili, A., Banikazemi, Z., & Sahebkar, A. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.11.098 · Cited by 517
Oral delivery of anticancer drugs: Challenges and opportunities
Thanki, K., Gangwal, R. P., Sangamwar, A. T., & Jain, S. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.04.020 · Cited by 499
Cevc, G., Gebauer, D., Stieber, J., Schätzlein, A., & Blume, G. (1998) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(97)00177-6 · Cited by 478
Application of Various Types of Liposomes in Drug Delivery Systems
Alavi, M., Karimi, N., & Safaei, M. (2017) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2017.002 · Cited by 466
Advanced drug delivery systems: Nanotechnology of health design A review
Safari, J., & Zarnegar, Z. (2014) · Journal of Saudi Chemical Society · doi:10.1016/j.jscs.2012.12.009 · Cited by 429
Hadjipanayis, C. G., Machaidze, R., Kaluzova, M., Wang, L., Schuette, A. J., Chen, H., Wu, X., & Mao, H. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1022 · Cited by 419
Basic Concepts of Microarrays and Potential Applications in Clinical Microbiology
Miller, M. B., & Tang, Y.-W. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00019-09 · Cited by 419
Lipid – An emerging platform for oral delivery of drugs with poor bioavailability
Chakraborty, S., Shukla, D., Mishra, B., & Singh, S. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.06.001 · Cited by 411
Ren, J., Shen, S., Wang, D., Xi, Z., Guo, L., Pang, Z., Qian, Y., Sun, X., & Jiang, X. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.01.025 · Cited by 408
Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
van der Meel, R., Vehmeijer, L. J. C., Kok, R. J., Storm, G., & van Gaal, E. V. B. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.012 · Cited by 398
Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures
Ragelle, H., Danhier, F., Préat, V., Langer, R., & Anderson, D. G. (2017) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1244187 · Cited by 390
Drummond, D. C., Noble, C. O., Guo, Z., Hong, K., Park, J. W., & Kirpotin, D. B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4007 · Cited by 380
Cubosomes: remarkable drug delivery potential
Karami, Z., & Hamidi, M. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.01.004 · Cited by 371
Oral insulin delivery by means of solid lipid nanoparticles.
Sarmento, B. F. C. C., Martins, S., Ferreira, D., & Souto, E. B. (2007) · PubMed Central · Cited by 363
Balakumar, K., Raghavan, C. V., selvan, N. T., prasad, R. H., & Abdu, S. (2013) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2013.08.025 · Cited by 324
Feldman, E. J., Lancet, J. E., Kolitz, J. E., Ritchie, E. K., Roboz, G. J., List, A. F., Allen, S. L., Asatiani, E., Mayer, L. D., Swenson, C., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.5961 · Cited by 310
Lipid-Based Drug Delivery Systems
Shrestha, H., Bala, R., & Arora, S. (2014) · Journal of Pharmaceutics · doi:10.1155/2014/801820 · Cited by 304
Müllertz, A., Ogbonna, A., Ren, S., & Rades, T. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01107.x · Cited by 295
Aditya, N. P., Macedo, A. S., Doktorovova, S., Souto, E. B., Kim, S., Chang, P.-S., & Ko, S. (2014) · LWT - Food Science and Technology · doi:10.1016/j.lwt.2014.04.058 · Cited by 293
Caminade, A.-M., & Turrin, C.-O. (2014) · J. Mater. Chem. B · doi:10.1039/c4tb00171k · Cited by 290
Clinical overview on Lipoplatin™: a successful liposomal formulation of cisplatin
Boulikas, T. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903114168 · Cited by 276
Khdair, A., Chen, D., Patil, Y., Ma, L., Dou, Q. P., Shekhar, M. P. V., & Panyam, J. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.09.004 · Cited by 275
Cubosome Dispersions as Delivery Systems for Percutaneous Administration of Indomethacin
Esposito, E., Cortesi, R., Drechsler, M., Paccamiccio, L., Mariani, P., Contado, C., Stellin, E., Menegatti, E., Bonina, F., & Puglia, C. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-8176-x · Cited by 259
Target Delivery and Cell Imaging Using Hyaluronic Acid-Functionalized Graphene Quantum Dots
Abdullah-Al-Nahain, Lee, J.-E., In, I., Lee, H., Lee, K. D., Jeong, J. H., & Park, S. Y. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400219u · Cited by 258
Dhawan, S., Kapil, R., & Singh, B. (2011) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01225.x · Cited by 256
Formulation and evaluation of ethosomes for transdermal delivery of lamivudine
Jain, S., Tiwary, A. K., Sapra, B., & Jain, N. K. (2007) · AAPS PharmSciTech · doi:10.1208/pt0804111 · Cited by 254
Matsumura, Y., Gotoh, M., Muro, K., Yamada, Y., Shirao, K., Shimada, Y., Okuwa, M., Matsumoto, S., Miyata, Y., Ohkura, H., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh092 · Cited by 253
Effective anti-tumor activity of oxaliplatin encapsulated in transferrin–PEG-liposome
Suzuki, R., Takizawa, T., Kuwata, Y., Mutoh, M., Ishiguro, N., Utoguchi, N., Shinohara, A., Eriguchi, M., Yanagie, H., & Maruyama, K. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.06.010 · Cited by 250
Serisier, D. J., Bilton, D., De Soyza, A., Thompson, P. J., Kolbe, J., Greville, H. W., Cipolla, D., Bruinenberg, P., Gonda, I., & the ORBIT-2 investigators (2013) · Thorax · doi:10.1136/thoraxjnl-2013-203207 · Cited by 250
Recent Advances in Novel Drug Carrier Systems
(2012) · InTech eBooks · doi:10.5772/2889 · Cited by 247
Mamot, C., Ritschard, R., Wicki, A., Stehle, G., Dieterle, T., Bubendorf, L., Hilker, C., Deuster, S., Herrmann, R., & Rochlitz, C. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70476-x · Cited by 244
Bhalekar, M. R., Pokharkar, V., Madgulkar, A., Patil, N., & Patil, N. (2009) · AAPS PharmSciTech · doi:10.1208/s12249-009-9199-0 · Cited by 241
Meng, J., Guo, F., Xu, H., Liang, W., Wang, C., & Yang, X.-D. (2016) · Scientific Reports · doi:10.1038/srep22390 · Cited by 236
Luo, Q., Zhao, J., Zhang, X., & Pan, W. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.10.013 · Cited by 234
Advances in lipid nanoparticles for siRNA delivery
Tam, Y., Chen, S., & Cullis, P. (2013) · Pharmaceutics · doi:10.3390/pharmaceutics5030498 · Cited by 229
Dubey, V., Mishra, D. K., & Jain, N. K. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.03.007 · Cited by 228
Self-citationHyperthermia-induced drug targeting
May, J. P., & Li, S.-D. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.758631 · Cited by 228
Čerpnjak, K., Zvonar, A., Gašperlin, M., & Vrečer, F. (2013) · Acta Pharmaceutica · doi:10.2478/acph-2013-0040 · Cited by 224
Lu, Y.-J., Wei, K.-C., Ma, C.-C. M., Yang, S.-Y., & Chen, J.-P. (2012) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.08.001 · Cited by 223
Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection
Clancy, J. P., Dupont, L., Konstan, M. W., Billings, J., Fustik, S., Goss, C. H., Lymp, J., Minic, P., Quittner, A. L., Rubenstein, R. C., et al. (2013) · Thorax · doi:10.1136/thoraxjnl-2012-202230 · Cited by 222
Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery
Park, J.-H., Cho, H.-J., Yoon, H. Y., Yoon, I.-S., Ko, S.-H., Shim, J.-S., Cho, J.-H., Park, J. H., Kim, K., Kwon, I. C., et al. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.11.016 · Cited by 221
Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug
Jain, A., Agarwal, A., Majumder, S., Lariya, N., Khaya, A., Agrawal, H., Majumdar, S., & Agrawal, G. P. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.09.003 · Cited by 217
Gupta, S., Chavhan, S., & Sawant, K. K. (2011) · Colloids and Surfaces A: Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2011.09.048 · Cited by 217
Batist, G., Gelmon, K. A., Chi, K. N., Miller, W. H., Chia, S. K. L., Mayer, L. D., Swenson, C. E., Janoff, A. S., & Louie, A. C. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0515 · Cited by 213
Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting
Mahajan, H. S., Mahajan, M. S., Nerkar, P. P., & Agrawal, A. (2014) · Drug Delivery · doi:10.3109/10717544.2013.838014 · Cited by 212
Ji, Z., Lin, G., Lu, Q., Meng, L., Shen, X., Dong, L., Fu, C., & Zhang, X. (2012) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2011.09.013 · Cited by 205
Tikekar, R. V., Pan, Y., & Nitin, N. (2013) · Food Research International · doi:10.1016/j.foodres.2012.12.027 · Cited by 205
Controlled pulmonary drug and gene delivery using polymeric nano-carriers
Beck-Broichsitter, M., Merkel, O. M., & Kissel, T. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.004 · Cited by 200
Overcoming poor oral bioavailability using nanoparticle formulations – opportunities and limitations
Desai, P. P., Date, A. A., & Patravale, V. B. (2012) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2011.12.001 · Cited by 199
Gan, L., Han, S., Shen, J., Zhu, J., Zhu, C., Zhang, X., & Gan, Y. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.06.015 · Cited by 196
Wang, Y., Guo, R., Cao, X., Shen, M., & Shi, X. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.12.060 · Cited by 189
Optimization of 5-fluorouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer
Yassin, A. E. B., Anwer, M. K., Mowafy, H. A., El-Bagory, I. M., Bayomi, M. A., & Alsarra, I. A. (2010) · International Journal of Medical Sciences · doi:10.7150/ijms.7.398 · Cited by 188
Lipid Based Vesicular Drug Delivery Systems
Jain, S., Jain, V., & Mahajan, S. C. (2014) · Advances in Pharmaceutics · doi:10.1155/2014/574673 · Cited by 181
Lipid Nanoparticulate Drug Delivery Systems: A Revolution in Dosage Form Design and Development
A., A., A., M., & F., P. (2012) · Recent Advances in Novel Drug Carrier Systems · doi:10.5772/50486 · Cited by 180
Han, S., Shen, J.-Q., Gan, Y., Geng, H.-M., Zhang, X.-X., Zhu, C.-L., & Gan, L. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.98 · Cited by 177
Cortes, J. E., Goldberg, S. L., Feldman, E. J., Rizzeri, D. A., Hogge, D. E., Larson, M., Pigneux, A., Recher, C., Schiller, G., Warzocha, K., et al. (2015) · Cancer · doi:10.1002/cncr.28974 · Cited by 175
Multi-functional nanocarriers for targeted delivery of drugs and genes
Jabr-Milane, L., van Vlerken, L., Devalapally, H., Shenoy, D., Komareddy, S., Bhavsar, M., & Amiji, M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.04.016 · Cited by 171
Seo, Y. G., Kim, D. H., Ramasamy, T., Kim, J. H., Marasini, N., Oh, Y.-K., Kim, D.-W., Kim, J. K., Yong, C. S., Kim, J. O., et al. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.05.034 · Cited by 163
Gautier, J., Allard-Vannier, É., Munnier, E., Soucé, M., & Chourpa, I. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.03.018 · Cited by 161
Targeted Cancer Therapy With Novel High Drug-Loading Nanocrystals
Liu, F., Park, J.-Y., Zhang, Y., Conwell, C., Liu, Y., Bathula, S. R., & Huang, L. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22112 · Cited by 159
Nanotechnology and human health: risks and benefits
Cattaneo, A. G., Gornati, R., Sabbioni, E., Chiriva‐Internati, M., Cobos, E., Jenkins, M. R., & Bernardini, G. (2010) · Journal of Applied Toxicology · doi:10.1002/jat.1609 · Cited by 158
Lipid nanoparticles for short interfering RNA delivery
Leung, A. K. K., Tam, Y. Y. C., & Cullis, P. R. (2014) · Advances in genetics · doi:10.1016/b978-0-12-800148-6.00004-3 · Cited by 158
Doxorubicin-loaded solid lipid nanoparticles to overcome multidrug resistance in cancer therapy
Kang, K. W., Chun, M., Kim, O., Subedi, R. K., Ahn, S., Yoon, J., & Choi, H. (2010) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2009.12.006 · Cited by 156
Cationic solid lipid nanoparticles for co-delivery of paclitaxel and siRNA
Yu, Y. H., Kim, E. J., Park, D. E., Shim, G., Lee, S. B., Kim, Y. B., Kim, C., & Oh, Y. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.11.002 · Cited by 154
Brain delivery of olanzapine by intranasal administration of transfersomal vesicles
Ha, S., Mahmoud, A. A. K., Kamel, A. O., Hady, M. A., & Awad, G. A. S. (2012) · Journal of Liposome Research · doi:10.3109/08982104.2012.700460 · Cited by 152
Fu, F., Wu, Y., Zhu, J., Wen, S., Shen, M., & Shi, X. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am504849x · Cited by 151
Systemic p53 Gene Therapy of Cancer with Immunolipoplexes Targeted by Anti-Transferrin Receptor scFv
Xu, L., Tang, W., Huang, C., Alexander, W., Xiang, L., Pirollo, K. F., Rait, A. S., & Chang, E. H. (2001) · Molecular Medicine · doi:10.1007/bf03401962 · Cited by 150
Yong, K., Wang, Y., Roy, I., Hu, R., Swihart, M. T., Law, W., Kwak, S. K., Ye, L., Liu, J., Mahajan, S. D., et al. (2012) · Theranostics · doi:10.7150/thno.3692 · Cited by 142
Dragovich, T., Mendelson, D. S., Kurtin, S. E., Richardson, K., Hoff, D. D. V., & Hoos, A. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0235-4 · Cited by 142
Awada, A. H., Bondarenko, I., Bonneterre, J. M., Nowara, E., Ferrero, J.-M., Bakshi, A. V., Wilke, C., & Piccart, M. J. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu025 · Cited by 142
Self-microemulsifying drug delivery system improves curcumin dissolution and bioavailability
Wu, X., Xu, J., Huang, X., & Wen, C. (2010) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2010.489560 · Cited by 137
Ahmed, T. A. (2014) · Journal of Liposome Research · doi:10.3109/08982104.2014.950276 · Cited by 136
Abd-Elal, R. M. A., Shamma, R. N., Rashed, H. M., & Bendas, E. R. (2016) · Drug Delivery · doi:10.1080/10717544.2016.1183721 · Cited by 135
Fathi, H. A., Allam, A., Elsabahy, M., Fetih, G. N., & El‐Badry, M. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.11.064 · Cited by 134
A pH‐Responsive Drug‐Delivery Platform Based on Glycol Chitosan–Coated Liposomes
Yan, L., Crayton, S. H., Thawani, J. P., Amirshaghaghi, A., Tsourkas, A., & Cheng, Z. (2015) · Small · doi:10.1002/smll.201501412 · Cited by 131
Acid degradable ZnO quantum dots as a platform for targeted delivery of an anticancer drug
Muhammad, F., Guo, M., Guo, Y., Qi, W., Qu, F., Sun, F., Zhao, H., & Zhu, G. (2011) · Journal of Materials Chemistry · doi:10.1039/c1jm12119g · Cited by 129
Chime, S. A. (2013) · African Journal of Pharmacy and Pharmacology · doi:10.5897/ajppx2013.0004 · Cited by 128
Patel, H., Barot, B. S., Parejiya, P. B., Shelat, P., & Shukla, A. (2012) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2012.08.011 · Cited by 126
Qumbar, M., Zafar, A., Imam, S. S., Ali, J., Ahmad, J., & Ali, A. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.06.043 · Cited by 126
Stathopoulos, G. P., Antoniou, D., Dimitroulis, J., Michalopoulou, P., Bastas, A., Marosis, K., Stathopoulos, J., Provata, A., Yiamboudakis, P., Veldekis, D., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq234 · Cited by 125
Mishra, D. K., Garg, M., Dubey, V., Jain, S. K., & Jain, N. K. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20737 · Cited by 124
Self-citationRoy, A. C., Park, S. R., Cunningham, D., Kang, Y., Chao, Y., Chen, L., Rees, C., Lim, H. Y., Tabernero, J. M., Ramos, F. J., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt002 · Cited by 123
Thakkar, H. P., Nangesh, J., Parmar, M. P., & Patel, D. (2011) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.84463 · Cited by 122
Martins, S., Tho, I., Reimold, I., Fricker, G., Souto, E. B., Ferreira, D., & Brandl, M. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.09.054 · Cited by 120
Dhas, N. L., Ige, P. P., & Kudarha, R. R. (2015) · Powder Technology · doi:10.1016/j.powtec.2015.04.053 · Cited by 119
Kim, S. S., Rait, A. S., Kim, E. H., Pirollo, K. F., & Chang, E. H. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.09.005 · Cited by 118
Justin, R., Tao, K., Román, S., Chen, D., Xu, Y., Geng, X., Ross, I. M., Grant, R. T., Pearson, A. J., Zhou, G., et al. (2015) · Carbon · doi:10.1016/j.carbon.2015.06.070 · Cited by 117
Shen, J., Deng, Y., Jin, X., Ping, Q., Su, Z., & Li, L. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.10.008 · Cited by 116
Yu, F., Li, Y., Chen, Q., He, Y., Wang, H., Liu, Y., Guo, S., Meng, Z., Cui, J.-H., Xue, M., et al. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.03.019 · Cited by 116
Deshpande, P. P., Jhaveri, A. M., Pattni, B. S., Biswas, S., & Torchilin, V. P. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1435747 · Cited by 116
Camp, E. R., Wang, C., Little, E. C., Watson, P. M., Pirollo, K. F., Rait, A. S., Cole, D. J., Chang, E. H., & Watson, D. K. (2013) · Cancer Gene Therapy · doi:10.1038/cgt.2013.9 · Cited by 115
Kang, M. H., Wang, J., Makena, M. R., Lee, J.-S., Paz, N., Hall, C. P., Song, M. M., Calderon, R. I., Cruz, R. E., Hindle, A., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1882 · Cited by 114
Feng, N. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s28761 · Cited by 110
Nasr, M., Mansour, S., Mortada, N. D., & EL-Shamy, A.-E. (2008) · AAPS PharmSciTech · doi:10.1208/s12249-007-9028-2 · Cited by 110
Löhr, M. J., Haas, S., Bechstein, W. O., Bodoky, G., Cwiertka, K., Fischbach, W., Fölsch, U. R., Jäger, D., Osinsky, D., Prausová, J., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr379 · Cited by 108
Transfersomal Nanoparticles for Enhanced Transdermal Delivery of Clindamycin
Abdellatif, A. A. H., & Tawfeek, H. M. (2015) · AAPS PharmSciTech · doi:10.1208/s12249-015-0441-7 · Cited by 108
Yadav, V. R., Suresh, S., Devi, K., & Yadav, S. (2009) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.61.03.0005 · Cited by 102
Targeted delivery of methotrexate to skeletal muscular tissue by thermosensitive magnetoliposomes
Zhu, L., Huo, Z., Wang, L., Tong, X., Xiao, Y. Z., & Ni, K. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.12.003 · Cited by 102
Vyas, S. P., Subhedar, R., & Jain, S. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.3.0005 · Cited by 102
Fasol, U., Frost, A., Büchert, M., Arends, J., Fiedler, U., Scharr, D., Scheuenpflug, J., & Mross, K. B. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr300 · Cited by 101
Phytosome-hyaluronic acid systems for ocular delivery of L-carnosine
Abdelkader, H., Longman, M. R., Alany, R. G., & Pierscionek, B. K. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s104774 · Cited by 96
Chhabra, G., Chuttani, K., Mishra, A. K., & Pathak, K. (2011) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2010.550050 · Cited by 94
Nanosuspension improves tretinoin photostability and delivery to the skin
Lai, F., Pireddu, R., Corrias, F., Fadda, A. M., Valenti, D., Pini, E., & Sinico, C. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.10.007 · Cited by 93
Clotrimazole-loaded nanostructured lipid carrier hydrogels: Thermal analysis and in vitro studies
Ravani, L., Esposito, E., Bories, C., Moal, V. L.-L., Loiseau, P. M., Djabourov, M., Cortesi, R., & Bouchemal, K. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.06.015 · Cited by 93
Cao, W., Zhou, J., Mann, A., Wang, Y., & Zhu, L. J. (2011) · Biomacromolecules · doi:10.1021/bm200487h · Cited by 93
Synthesis and Evaluation of Paclitaxel-Loaded Gold Nanoparticles for Tumor-Targeted Drug Delivery
Paciotti, G. F., Zhao, J., Cao, S., Brodie, P. J., Tamarkin, L., Huhta, M. S., Myer, L. D., Friedman, J., & Kingston, D. G. I. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00405 · Cited by 93
Conlin, A. K., Seidman, A. D., Bach, A. M., Lake, D. E., Dickler, M. N., D’Andrea, G. M., Traina, T. A., Danso, M. A., Brufsky, A., Saleh, M. N., et al. (2010) · Clinical Breast Cancer · doi:10.3816/cbc.2010.n.036 · Cited by 91
El-Zaafarany, G. M., Soliman, M. E., Mansour, S., & Awad, G. A. S. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.02.038 · Cited by 89
Slingerland, M., Guchelaar, H., Rosing, H., Scheulen, M. E., van Warmerdam, L. J. C., Beijnen, J. H., & Gelderblom, H. A. J. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.10.009 · Cited by 89
Development and physicochemical evaluation of pharmacosomes of diclofenac
Semalty, A., Semalty, M., Singh, D., et al. (2009) · Acta Pharmaceutica · doi:10.2478/v10007-009-0023-x · Cited by 86
Engineered chylomicron mimicking carrier emulsome for lymph targeted oral delivery of methotrexate
Paliwal, R., Paliwal, S. R., Mishra, N., Mehta, A., & Vyas, S. P. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.06.026 · Cited by 85
Chen, Q., Zheng, J., Yuan, X., Wang, J., & Zhang, L. (2017) · Materials Science and Engineering C · doi:10.1016/j.msec.2017.08.026 · Cited by 85
Challenges in the Use of Carbon Nanotubes for Biomedical Applications
Mehra, N. K., Jain, A., Lodhi, N., Raj, R., Dubey, V., Mishra, D. K., Nahar, M., & Jain, N. K. (2008) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v25.i2.20 · Cited by 83
Self-citationSorafenib and gadolinium co-loaded liposomes for drug delivery and MRI-guided HCC treatment
Xiao, Y., Liu, Y., Yang, S., Zhang, B., Wang, T., Jiang, D., Zhang, J., Yu, D., & Zhang, N. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.01.016 · Cited by 82
Mishra, D. K., Mishra, H., Mishra, P. K., Nahar, M., Dubey, V., & Jain, N. K. (2010) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3xk53 · Cited by 81
Self-citationRecent Advances in Microarray Technologies for Proteomics
Sun, H., Chen, G. Y. J., & Yao, S. Q. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.04.009 · Cited by 81
Xu, P., Yang, Z., Chen, M., Yang, M., Chen, J., & Fang, W. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s54967 · Cited by 79
Lu, C. S., Perez-Soler, R., Piperdi, B., Walsh, G. L., Swisher, S. G., Smythe, W. R., Shin, H. J. C., Ro, J. Y., Feng, L., Truong, M. T., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.802 · Cited by 79
A composite hydrogel system containing glucose-responsive nanocarriers for oral delivery of insulin
Li, L., Jiang, G., Yu, W., et al. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.06.059 · Cited by 78
The use of Nanocarriers for Drug Delivery in Cancer Therapy David R. Khan
Khan, D. R. (2010) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000024 · Cited by 77
Enhanced oral bioavailability of an antipsychotic drug through nanostructured lipid carriers
Natarajan, J., Hingarh, P. K., Radhakrishnan, A., Selvaraj, J., Anbarasan, A., Sankaran, S., & Nagaraju, G. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.01.121 · Cited by 77
Hamaguchi, T., Matsumura, Y., Nakanishi, Y., Muro, K., Yamada, Y., Shimada, Y., Shirao, K., Niki, H., Hosokawa, S., Tagawa, T., et al. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb02495.x · Cited by 74
Comparative in vitro and in vivo evaluation of lipid based nanocarriers of Huperzine A
Patel, P. A., Patil, S. C., Kalaria, D. R., Kalia, Y. N., & Patravale, V. B. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.014 · Cited by 74
A study of the formulation design of acoustically active lipospheres as carriers for drug delivery
Fang, J., Hung, C., Liao, M.-H., & Chien, C.-C. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.01.008 · Cited by 72
Carbon nanotubes and their toxicity
Jain, A., Mehra, N. K., Lodhi, N., Dubey, V., Mishra, D. K., Jain, P. K., & Jain, N. K. (2007) · Nanotoxicology · doi:10.1080/17435390701639688 · Cited by 72
Self-citationBollhorst, T., Shahabi, S., Wörz, K., Petters, C., Dringen, R., Maas, M., & Rezwan, K. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201408515 · Cited by 65
Ultrasound-mediated drug delivery using liposomes modified with a thermosensitive polymer
Ninomiya, K., Kawabata, S., Tashita, H., & Shimizu, N. (2013) · Ultrasonics Sonochemistry · doi:10.1016/j.ultsonch.2013.07.014 · Cited by 64
Design of soft lipid nanocarriers based on bioactive vegetable oils with multiple health benefits
Lăcătuşu, I., Niculae, G., Badea, N. M., Stan, R., Popa, O., Oprea, O., & Meghea, A. (2014) · Chemical Engineering Journal · doi:10.1016/j.cej.2014.02.041 · Cited by 61
Salama, A. H., & Aburahma, M. H. (2015) · Pharmaceutical Development and Technology · doi:10.3109/10837450.2015.1048553 · Cited by 60
Mao, W., Kim, H. S., Son, Y. J., Kim, S., & Yoo, H. S. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.003 · Cited by 57
Thermally Switched Release from Nanoparticle Colloidosomes
Zhou, S., Fan, J., Datta, S. S., Guo, M., Guo, X., & Weitz, D. A. (2013) · Advanced Functional Materials · doi:10.1002/adfm.201301030 · Cited by 55
Chien, A. J., Illi, J., Ko, A. H., Korn, W. M., Fong, L. H., Chen, L.-M., Kashani–Sabet, M., Ryan, C. J., Rosenberg, J. E., Dubey, S., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0522 · Cited by 49
Mahalingam, D., Nemunaitis, J. J., Malik, L., Sarantopoulos, J., Weitman, S. D., Sankhala, K. K., Hart, J., Kousba, A. A., Gallegos, N. S., Anderson, G. G., et al. (2014) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-014-2602-x · Cited by 48
Carbohydrate modified ultrafine ceramic nanoparticles for allergen immunotherapy
Pandey, R. S., Sahu, S., Sudheesh, M. S., Madan, J., Kumar, M., & Dixit, V. K. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.02.004 · Cited by 47
He, R.-X., Ye, X., Li, R., Chen, W., Chen, W., Tao, G., Huang, T., Nie, X., Chen, H., Peng, D., et al. (2016) · Journal of Liposome Research · doi:10.1080/08982104.2016.1191021 · Cited by 47
Wetzler, M., Thomas, D. A., Wang, E. S., Shepard, R. C., Ford, L. A., Heffner, T. L., Parekh, S. S., Andreeff, M., O'Brien, S. M., & Kantarjian, H. M. (2013) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2013.03.015 · Cited by 45
Ruiz, M. E., Gantner, M. E., & Talevi, A. (2013) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574891x113089990038 · Cited by 45
Lacatusu, I., Badea, N. M., Badea, G., Oprea, O., Mihaila, M. A., Kaya, D. A., Stan, R., & Meghea, A. (2015) · Materials Science and Engineering C · doi:10.1016/j.msec.2015.06.019 · Cited by 44
A phase I and pharmacokinetic study of liposomal vinorelbine in patients with advanced solid tumor
Yang, S., Lin, C., Lin, Z., et al. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9522-3 · Cited by 43
Mittal, R., Sharma, A., & Arora, S. (2012) · Journal of Pharmaceutics · doi:10.1155/2013/680580 · Cited by 40
Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions
Raj, R., Mongia, P. R., Sahu, S. K., & Ram, A. (2016) · Current Drug Targets · doi:10.2174/1389450116666150722141607 · Cited by 36
NOVEL APPROACHES IN LIPID BASED DRUG DELIVERY SYSTEMS
Asadujjaman, M., & Mishuk, A. U. (2013) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v3i4.578 · Cited by 31
Tumor Burden Talks in Cancer Treatment with PEGylated Liposomal Drugs
Lin, Y.-Y., Kao, H.-W., Li, J.-J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063078 · Cited by 29
Archaeosome: As New Drug Carrier for Delivery of Paclitaxel to Breast Cancer
Alavi, S. E., Mansouri, H., Esfahani, M. K. M., et al. (2013) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-013-0305-4 · Cited by 29
Silica-Encapsulated Efficient and Stable Si Quantum Dots with High Biocompatibility
Amato, G. (2010) · Nanoscale Research Letters · doi:10.1007/s11671-010-9619-9 · Cited by 25
Moghimipour, E., Kargar, M., Ramezani, Z., & Handali, S. (2013) · Archaea · doi:10.1155/2013/782012 · Cited by 21
Bhargava, A., Mishra, D. K., Khan, S., Varshney, S., Banerjee, S., & Mishra, P. K. (2013) · Nanomedicine · doi:10.2217/nnm.12.164 · Cited by 15
Self-citationNanonośniki jako nowoczesne transportery w kontrolowanym dostarczaniu leków
Niemirowicz, K., & Car, H. (2012) · Chemik · Cited by 8
Cited by
Overcoming barriers by local drug delivery with liposomes
Antimisiaris, S. G., Marazioti, A., Kannavou, M., Natsaridis, E., Gkartziou, F., Kogkos, G., & Mourtas, S. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.019 · Cited by 339
In vitro and in vivo characterization of pharmaceutical nanocarriers used for drug delivery
Jain, A. K., & Thareja, S. (2019) · Artificial Cells, Nanomedicine, and Biotechnology · doi:10.1080/21691401.2018.1561457 · Cited by 319
Engineering nano-drug biointerface to overcome biological barriers toward precision drug delivery
Waheed, S., Li, Z., Zhang, F., Chiarini, A., Armato, U., & Wu, J. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01605-4 · Cited by 259
Cancer stem cells-emanated therapy resistance: Implications for liposomal drug delivery systems
Dianat-Moghadam, H., Heidarifard, M., Jahanban-Esfahlan, R., Panahi, Y., Hamishehkar, H., Pouremamali, F., Rahbarghazi, R., & Nouri, M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.08.043 · Cited by 140
Metadata
- Authors
- Mishra, D. K., Shandilya, R., & Mishra, P. K.
- Venue
- Nanomedicine: Nanotechnology, Biology and Medicine
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 14
- Issue
- 7
- Pages
- 2023-2050
- ISSN
- 1549-9634 (ISSN-L)
- OpenAlex
- W2810417738
- Cited by
- 258
- References
- 160
- FWCI
- 5.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.